How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Gait Assessment and Training System Market
- By Product Type: Wearable Gait Analysis Systems, Non-Wearable Gait Analysis Systems, Treadmill-Based Gait Training Systems, Overground Gait Training Systems, Robotic Gait Training Systems
- By Technology: Motion Capture Systems, Pressure Sensor Systems, Inertial Measurement Units (IMUs), Electromyography (EMG) Systems, Force Plate Systems
- By End User: Hospitals, Rehabilitation Centers, Research Institutes, Sports Clinics, Home Care Settings
- By Application: Neurological Rehabilitation, Orthopedic Rehabilitation, Sports Performance Analysis, Fall Risk Assessment, Geriatric Mobility Training
- By Component: Hardware, Software, Services
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Wearable Gait Analysis Systems leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 303 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.183 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.191 →
Full report · locked preview
Everything inside the Gait Assessment and Training System Market report
A complete, evidence-based study - 12 chapters and 127 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Technology 5
End User 5
Application 5
Component 3
Companies profiled
Tekscan Inc.
Zebris Medical GmbH
Moticon ReGo AG
Biodex Medical Systems Inc.
Noraxon USA Inc.
GAIT Up (a division of Delsys
Inc.)
ProtoKinetics LLC
RSscan International
Vicon Motion Systems Ltd.
DorsaVi Pty Ltd
Reha Technology AG
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Tekscan Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Zebris Medical GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Moticon ReGo AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Biodex Medical Systems Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Noraxon USA Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →GAIT Up (a division of Delsys
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Inc.)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →ProtoKinetics LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →RSscan International
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Vicon Motion Systems Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →DorsaVi Pty Ltd
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Reha Technology AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →APDM Wearable Technologies (a Clario company)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Gait Up (Delsys)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →BTS Bioengineering S.p.A.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Walker View (by Tecnobody)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,769M by 2033 · 4.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Wearable Gait Analysis Systems54.1
- Non-Wearable Gait Analysis Systems10.1
- Treadmill-Based Gait Training Systems12.7
- Overground Gait Training Systems15.7
- Robotic Gait Training Systems7.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,599M → $1,989M · 2.8%
Europe$1,114M → $1,545M · 4.2%
Asia Pacific$1,017M → $1,438M · 4.4%
Latin America$629.8M → $811.9M · 3.2%
Middle East and Africa$484.4M → $663.6M · 4.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.232026
4.222027
4.252028
4.252029
4.262030
4.282031
4.302032
4.302033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Tekscan Inc.12.8
- Zebris Medical GmbH20.9
- Moticon ReGo AG12.5
- Biodex Medical Systems Inc.3.8
- Noraxon USA Inc.9.8
- GAIT Up (a division of Delsys12.1
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type13.8%
Technology18.5%
End User23.9%
Application19.2%
Component24.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.8
- Europe24.0
- Asia Pacific22.3
- Latin America12.6
- Middle East and Africa10.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Tekscan Inc. | 73 | 96 | 86 | 92 | 80 | 74 | 84 |
| Zebris Medical GmbH | 68 | 86 | 87 | 83 | 80 | 73 | 80 |
| Moticon ReGo AG | 80 | 68 | 64 | 87 | 70 | 79 | 75 |
| Biodex Medical Systems Inc. | 63 | 78 | 58 | 81 | 75 | 58 | 69 |
| Noraxon USA Inc. | 51 | 64 | 60 | 53 | 75 | 51 | 59 |
| GAIT Up (a division of Delsys | 56 | 53 | 69 | 54 | 46 | 68 | 58 |
| Inc.) | 58 | 55 | 51 | 55 | 50 | 58 | 55 |
| ProtoKinetics LLC | 52 | 47 | 41 | 54 | 56 | 51 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Tekscan Inc.
- Zebris Medical GmbH
- Moticon ReGo AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Tekscan Inc. | ◐ | ◐ | ✓ | ✓ | ✓ | ◐ |
| Zebris Medical GmbH | ◐ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Moticon ReGo AG | ◐ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Biodex Medical Systems Inc. | ◐ | ◐ | − | ✓ | ◐ | − |
| Noraxon USA Inc. | ◐ | − | − | ◐ | − | − |
| GAIT Up (a division of Delsys | ◐ | − | ◐ | ◐ | − | ◐ |
| Inc.) | − | − | ◐ | ◐ | − | ◐ |
| ProtoKinetics LLC | − | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Tekscan Inc.84
2Zebris Medical GmbH80
3Moticon ReGo AG75
4Biodex Medical Systems Inc.69
5Noraxon USA Inc.59
6GAIT Up (a division of Delsys58
7Inc.)55
8ProtoKinetics LLC50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Tekscan Inc.Zebris Medical GmbH
Challenger2
Strong scale, closing on the leaders.
Moticon ReGo AGBiodex Medical Systems Inc.
Contender2
Focused players with pockets of strength.
Noraxon USA Inc.GAIT Up (a division of Delsys
Niche2
Specialists in a single segment or region.
Inc.)ProtoKinetics LLC
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Gait Assessment and Training System Market — a $166M beachhead inside a $3.03B market.
Beachhead (SOM)$166Mobtainable near-term
Serviceable (SAM)$1.18Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Wearable Gait Analysis Systems
Best fit — highest urgency & budget in Product Type.
Economic buyer76 fit
Non-Wearable Gait Analysis Systems
Strong fit — clear ROI and a fast path to value.
End user69 fit
Treadmill-Based Gait Training Systems
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Technology & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel30%
Digital / self-serve19%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Gait Assessment and Training System Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified23%
Evaluation12%
Closed-won8%
$16.0KCAC
$67KLTV
4.2:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Gait Assessment and Training System Market is a resilient opportunity — $3.58B by 2033, compounding at 4.4%.
TAM · 2025$2.55Btoday
TAM · 2033$3.58Bforecast
CAGR4.4%2027–2033
Cumulative$27.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.58BTotal addressable market
SAM$1.48BServiceable available market
SOM$261MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.4% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.58BLarge & growingTAM by 2033 at 4.4% CAGR
$1.48BServiceable nowreachable with today’s model
$261MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.80BBear2.8% CAGR
$3.58BBase4.4% CAGR
$4.59BBull5.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Technology optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Gait Assessment and Training System Market — a $2.06B market by 2033. Plan: grow share from 7.8% to 14.8%.
Market size · 2033$2.06Btotal addressable
Market CAGR5.4%2027–2033
Target share14.8%from 7.8% today
Revenue ambition$305Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.8% | 14.8% | At risk |
| Revenue | $149M | $305M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 37.2% | 44.8% | On track |
| Customer retention | 86.8% | 96.7% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Technology capability
A defensible second engine — invest in Technology to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Technology
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $45M capacity & capability investment
- Greenlight bolt-on M&A in Technology
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAt risk
- Input-cost & supply riskBehind
- Regulatory / policy changeAhead
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Gait Assessment and Training System Market conversation — a $6.74B market you can size, segment and defend in minutes.
Market size · 2033$6.74Btotal opportunity
Growth10.8%CAGR to 2033
Addressable buyers1,197+accounts in scope
Typical ROI6.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.7×return on cost, year one
< 4 mopayback period
$81K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Tekscan Inc.Zebris Medical GmbHMoticon ReGo AGBiodex Medical Systems Inc.Noraxon USA Inc.GAIT Up (a division of DelsysInc.)ProtoKinetics LLC+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Gait Assessment and Training System Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Gait Assessment and Training System Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Gait and Balance System Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportGait Analyzer Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportFluorescence Detectors Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportGait Analysis Sensor Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportGene Knockdown Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportGadoteridol Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportGadoteridol Injection Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportGadoteric Acid Meglumine Salt Injection Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportGadoterate Meglumine Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportGadopentetic Acid Dimeglumine Salt Injection Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportGadopentetate Dimeglumine Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportDimethyl Sulfone (CAS 67-71-0) Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.